In this issue:
BV/AVD for elderly untreated Hodgkin lymphoma
T-cell ALL: COG AALL0434 methotrexate randomisation
ctDNA predicts outcomes in DLBCL
IgLV3-21 defines a poor prognostic subgroup in CLL
Bone marrow biopsy in PET-staged Hodgkin lymphoma
Brentuximab vedotin in paediatric R/R Hodgkinlymphoma and ALCL
Intensive treatment in advanced Hodgkin lymphoma
Everolimus + consolidation therapy in AML
Obinutuzumab, ibrutinib, + venetoclax in R/R CLL
Bendamustine + rituximab in elderly low-tumour burden follicular lymphoma
Please login below to download this issue (PDF)